On the other hand, although IL-22 administration resulted in more severe mucosal injury in colitis models [96], prophylactic treatment with IL-22 in Citrobacter rodentium-induced colitis models ameliorated the intestinal epithelial dysfunction [97]. The gene discussed is IL22; the disease is colitis.